Lactobacilli, bifidobacteria and E-coli nissle induce pro- an anti-inflammatory cytokines in peripheral blood mononuclear cells

被引:94
作者
Helwig, Ulf
Lammers, Karen M.
Rizzello, Fernando
Brigidi, Patricia
Rohleder, Verena
Caramelli, Elisabetta
Gionchetti, Paolo
Schrezenmeir, Juergen
Foelsch, Ulrich R.
Schreiber, Stefan
Campieri, Massimo
机构
[1] Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany
[2] Univ Bologna, Dept Internal Med & Gastroenterol, Policlin S Orsola, I-40138 Bologna, Italy
[3] Univ Bologna, Inst Microbiol, I-40138 Bologna, Italy
[4] Fed Res Ctr Nutr & Food, Inst Physiol & Biochem Nutr, D-24103 Kiel, Germany
关键词
Lactobacilli; Bifidobacteria; probiotics; interleukin-10; tumor necrosis factor-alpha; interleukin-1; beta; peripheral blood mononuclear cells;
D O I
10.3748/wjg.v12.i37.5978
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate whether the stimulation of peripheral blood mononuclear cells (PBMNC) with the cell debris and cell extraction of different probiotic strains is similar or species specific. METHODS: Three strains of bifidobacteria, 4 strains of lactobacilli, and E coli nissle were sonicated and centrifuged in order to divide them into cell extract and cell debris. PBMNC were separated by density gradient and incubated for 36 h with either the cell debris or the cell extract of single strains of probiotic bacteria in doses from 10(2) to 10(8) CFU/mL. Cell supernatants were taken and interleukin (IL)-10, IL-1 beta, and tumor necosis factor (TNF)-alpha were determined by ELISA. RESULTS: Depending on the species super-family, the strains had different stimulation patterns. Except for both L. casei strains, the cell extract of bifidobacteria and lactobacilli had less stimulating capacity than cell debris, whereas the cell extract of E. coli nissle had similar stimulating properties to that of the cell debris of the strain and significantly more stimulating capacity than that of bifidobacteria and lactobacilli. The cell debris of bifidobacteria stimulated more cytokine release than the cell debris of lactobacilli. The cell debris of lactobacilli did not have a stimulating capacity when lower concentrations were used. Neither cell extraction nor cell debris had an inhibitory effect on the production of the tested cytokines by stimulated PBMNC. CONCLUSION: The incubation of probiotic strains, which have been used in clinical trials for inflammatory diseases, with immunocompetent cells leads to different species specific reactions. High IL-10 response to cell debris of bifidobacteria and E coli nissle can be found. This corresponds to positive effects of bifidobacteria and E coli nissle in clinical trials for inflammatory bowel disease compared to negative outcomes obtained with lactobacilli. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:5978 / 5986
页数:9
相关论文
共 42 条
[1]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[2]   Bacteria as the cause of ulcerative colitis [J].
Campieri, M ;
Gionchetti, P .
GUT, 2001, 48 (01) :132-135
[3]   T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans [J].
Duchmann, R ;
May, E ;
Heike, M ;
Knolle, P ;
Neurath, M ;
zum Büschenfelde, KHM .
GUT, 1999, 44 (06) :812-818
[4]  
Edwards CA, 2002, BRIT J NUTR, V88, pS11, DOI [10.1079/BJNBJN2002580, 10.1079/BJN2002625]
[5]   Inflammatory bowel disease: Etiology and pathogenesis [J].
Fiocchi, C .
GASTROENTEROLOGY, 1998, 115 (01) :182-205
[6]   Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis [J].
Fiorucci, S ;
Distrutti, E ;
Mencarelli, A ;
Barbanti, M ;
Palazzini, E ;
Morelli, A .
DIGESTION, 2002, 66 (04) :246-256
[7]   Colonization of microflora in mice: mucosal defense against luminal bacteria [J].
Fukushima, K ;
Sasaki, I ;
Ogawa, H ;
Naito, H ;
Funayama, Y ;
Matsuno, S .
JOURNAL OF GASTROENTEROLOGY, 1999, 34 (01) :54-60
[8]   Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309
[9]   Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Helwig, U ;
Venturi, A ;
Lammers, KM ;
Brigidi, P ;
Vitali, B ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2003, 124 (05) :1202-1209
[10]   Probiotics in infective diarrhoea and inflammatory bowel diseases [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Campieri, M .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (05) :489-493